Healthcare

Scholars propose to modify the current regulatory regime for animal-based medical diagnostics.

Current testing practices in the pharmaceutical industry exploit social and racial inequities.

Experts examine how regulatory policies disproportionately affect communities of color.

China’s approach to regulatory law has both helped and hindered the government’s response to COVID-19.

The United Kingdom’s lockdown measures prompt questions of its legality.

Israel’s executives have authority to combat COVID-19, but they appear to be abusing their power.

Italy’s early missteps in responding to the coronavirus can teach the world lessons on responding to pandemics.

Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.

Scholars urge regulators to help level the playing field in contracting between health plans and hospitals.

The Trump Administration encourages states to use “innovation waivers” to find new ways to lower costs.

Scholar argues that agencies should collect evidence on surgical procedures to help implement best practices.

Scholar weighs the possibility of regulating medical artificial intelligence like human professionals.